Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (SHE:002399)
China · Delayed Price · Currency is CNY 9.83
-0.06 (-0.61%)
Sep 4, 2026, 3:04 PM CST
SHE:002399 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 1,520 | 1,346 | 1,689 | 1,766 | 2,139 | 2,944 |
Short-Term Investments | - | - | - | 206.2 | - | - |
Trading Asset Securities | 1,918 | 1,484 | 868.42 | 414.18 | 1,312 | 981.16 |
Cash & Short-Term Investments | 3,438 | 2,830 | 2,557 | 2,386 | 3,450 | 3,925 |
Cash Growth | 12.26% | 10.66% | 7.18% | -30.85% | -12.10% | 8.59% |
Accounts Receivable | 1,241 | 1,368 | 1,187 | 1,275 | 1,626 | 1,543 |
Other Receivables | 20.43 | 301.39 | 329.63 | 121.89 | 134.82 | 243.81 |
Receivables | 1,261 | 1,669 | 1,516 | 1,396 | 1,761 | 1,787 |
Inventory | 3,923 | 4,447 | 5,394 | 6,654 | 6,844 | 4,708 |
Prepaid Expenses | - | - | - | 111.28 | - | - |
Other Current Assets | 610.83 | 205.25 | 153.43 | 56.43 | 334.53 | 349.43 |
Total Current Assets | 9,233 | 9,151 | 9,621 | 10,604 | 12,390 | 10,770 |
Property, Plant & Equipment | 2,241 | 2,388 | 2,648 | 2,849 | 2,477 | 2,537 |
Long-Term Investments | 1,480 | 1,766 | 1,823 | 2,514 | 2,464 | 2,618 |
Goodwill | 2,233 | 2,305 | 2,357 | 2,322 | 2,351 | 2,152 |
Other Intangible Assets | 291.58 | 326.57 | 400.41 | 370.78 | 522.87 | 546.87 |
Long-Term Deferred Tax Assets | 341.38 | 320.44 | 282.51 | 320.5 | 141.48 | 121.72 |
Long-Term Deferred Charges | 169.98 | 178.96 | 185.65 | 18.64 | 244.71 | 241.88 |
Other Long-Term Assets | 318.19 | 195.32 | 25.48 | 203.87 | 224.95 | 120.85 |
Total Assets | 16,307 | 16,632 | 17,344 | 19,203 | 20,816 | 19,108 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Accounts Payable | 262.56 | 257.07 | 299.69 | 306.34 | 427.43 | 385.79 |
Accrued Expenses | 81.56 | 469.4 | 399.46 | 388 | 377.51 | 398.43 |
Short-Term Debt | 2,661 | 1,770 | 1,839 | 1,069 | 2,385 | 1,886 |
Current Portion of Long-Term Debt | 173.94 | 834.59 | 528.22 | 2,556 | 1,635 | 1,382 |
Current Portion of Leases | - | 30.1 | 38.82 | 37.8 | 35.69 | 31.75 |
Current Income Taxes Payable | 110.43 | 107.32 | 120.26 | 157.18 | 112.3 | 113.2 |
Current Unearned Revenue | 192.12 | 250.79 | 264.28 | 362.05 | 433.88 | 383.79 |
Other Current Liabilities | 513.9 | 233.65 | 209.56 | 110.24 | 168.2 | 210.34 |
Total Current Liabilities | 3,996 | 3,953 | 3,699 | 4,986 | 5,576 | 4,791 |
Long-Term Debt | 27.46 | 298.06 | 1,081 | 1,810 | 2,297 | 2,250 |
Long-Term Leases | 32.3 | 40.32 | 57.77 | 90.42 | 110.75 | 104 |
Long-Term Unearned Revenue | 39.19 | 42.58 | 27.28 | 30.43 | 32.55 | 16.67 |
Pension & Post-Retirement Benefits | - | - | 23.22 | 35.27 | 32.49 | 120.65 |
Long-Term Deferred Tax Liabilities | 220.6 | 207.07 | 242.49 | 252.57 | 328.92 | 275.36 |
Other Long-Term Liabilities | 9.92 | 10.19 | 10.35 | 10.15 | 29.39 | 26.44 |
Total Liabilities | 4,325 | 4,552 | 5,141 | 7,215 | 8,407 | 7,585 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Common Stock | 1,467 | 1,467 | 1,467 | 1,467 | 1,467 | 1,467 |
Additional Paid-In Capital | 5,864 | 5,864 | 5,865 | 7,529 | 5,859 | 5,944 |
Retained Earnings | 4,628 | 4,566 | 4,578 | 3,941 | 4,861 | 4,184 |
Comprehensive Income & Other | -26 | 133.96 | 238.17 | -1,024 | 125.52 | -183.36 |
Total Common Equity | 11,934 | 12,031 | 12,149 | 11,913 | 12,313 | 11,411 |
Minority Interest | 48.4 | 49.23 | 53.45 | 75.23 | 96.72 | 111.96 |
Shareholders' Equity | 11,982 | 12,080 | 12,202 | 11,988 | 12,409 | 11,523 |
Total Liabilities & Equity | 16,307 | 16,632 | 17,344 | 19,203 | 20,816 | 19,108 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Total Debt | 2,895 | 2,974 | 3,545 | 5,563 | 6,464 | 5,654 |
Net Cash (Debt) | 543.04 | -143.41 | -987.34 | -3,177 | -3,013 | -1,729 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | 0.37 | -0.10 | -0.67 | -2.15 | -2.05 | -1.18 |
Filing Date Shares Outstanding | 1,467 | 1,467 | 1,467 | 1,467 | 1,467 | 1,467 |
Total Common Shares Outstanding | 1,467 | 1,467 | 1,467 | 1,467 | 1,467 | 1,467 |
Working Capital | 5,237 | 5,198 | 5,922 | 5,618 | 6,814 | 5,978 |
Book Value Per Share | 8.13 | 8.20 | 8.28 | 8.12 | 8.39 | 7.78 |
Tangible Book Value | 9,409 | 9,400 | 9,391 | 9,220 | 9,439 | 8,712 |
Tangible Book Value Per Share | 6.41 | 6.41 | 6.40 | 6.28 | 6.43 | 5.94 |
Land | - | 33.74 | 34.51 | 34 | 33.43 | 30.61 |
Buildings | - | 1,837 | 1,788 | 1,915 | 1,480 | 1,450 |
Machinery | - | 2,505 | 1,996 | 1,961 | 1,892 | 1,719 |
Construction In Progress | - | 60.7 | 697.77 | 468.72 | 394.53 | 425.35 |
Leasehold Improvements | - | - | - | 15.43 | - | - |